pharmacovigilancesummit.com
An independent verification of whether this website looks safe, suspicious, or fraudulent. Backed by the structural signals listed below.
Risk score: some warning signs detected
SuspiciousThis website shows suspicious signs. Proceed with caution.
Public methodologySee how this risk assessment is builtGoogle has not yet flagged this URL as malicious.
Suggested actions
Open this section to see the recommended next steps for this case.
AI justification
This site is classified as suspicious based on the combination of risk signals observed in the analysis (domain age, lack of verifiable information, and content patterns). The website presents itself as a pharmacovigilance summit but the embedded metadata and organization details reference a banking technologies summit, indicating possible content or branding confusion. The domain is registered with a lesser-known registrar and the site uses financial-themed keywords like 'discount' which do not align clearly with the pharmacovigilance event, raising concerns about the site's true purpose. However, the presence of contact information and social profile links adds some legitimacy, though the mixed signals and branding inconsistencies warrant caution.
When AI is not enough, escalate to Human Layer.
For doubtful cases or important decisions, Desenmascara.me can escalate pharmacovigilancesummit.com to a professional human evaluation: context, evidence, external signals and a public human verdict attached to this report.
This is not a bought validation. The verdict can confirm, qualify, or correct the automated analysis.
14 signals unmasked
Key signals
Structured evidence collected for this domain.
Analysis time: 17.24s
Reserved for future use.
Source: openai
Next steps
Stay protected
Save the report, preserve the evidence, and share the finding with the right stakeholders.
Analysis history
Re-analyzeProfessional- Mar 21, 2026, 05:52 PMOpen reportSuspicious
Community experience
0 reportsShare your experience to help others. Reputation starts neutral and changes with positive or negative reports.